The longest-lived homozygous familial hypercholesterolemia as genetically-determined mild phenotype: an autopsy case of fh-tonami2

      Objectives: Homozygous familial hypercholesterolemia (HoFH) patients usually develop life-threatening atherosclerotic cardiovascular disease until their 3rd decade of life.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect